MAESTRIA consortium decided on study prolongation - MAESTRIA - Newsletter 04/24

In the MAESTRIA general assembly on 25.03.2024, the consortium members decided: the MAESTRIA – AFNET 10 study will be prolonged by 12 months.    

Following the decision of the EU consortium, the MAESTRIA – AFNET 10 enrolment phase can be extended to 30 months to achieve our target number of 600 patients. Now, the end of enrolment is scheduled for August 2025 at the latest. The 12 months follow-up phase is expected to be finished not later than August 2026.